Review examines de-escalating sleep apnoea therapy after GLP-1 weight loss
Cureus narrative review considers whether CPAP or other OSA treatment can be reduced following GLP-1 induced weight loss.
MH
By Maren Holt · Senior Reporter, GLP-1
Sep 17 07:20 ETSource: Cureus
The wire
- 01A narrative review addresses de-escalating obstructive sleep apnoea therapy after GLP-1 receptor agonist weight loss.
- 02Clinicians face decisions on adjusting OSA care as patients lose weight on GLP-1s.
- 03Narrative review offers no new trial data; protocols remain undefined.
From the source
Read at news.google.comDe-escalating Therapy in Obstructive Sleep Apnoea After Glucagon-Like Peptide-1 Receptor Agonist-Induced Weight Loss: A Narrative Review